CLSI M39A2

Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline, M39-A2

Clinical and Laboratory Standards Institute, 11/23/2005

Publisher: CLSI

File Format: PDF

$116.00$233.20

Description

Published:23/11/2005

Pages:60

CLSI M39A2 describes methods for recording and analysis of antimicrobial susceptibility test data, consisting of cumulative and ongoing summaries of susceptibility patterns of clinically significant microorganisms.

More CLSI standard pdf

CLSI T/DM08A

Urine Drug Testing in the Clinical Laboratory; Approved Guideline, T/DM08-A

$90.00 $180.00

CLSI M26-A

Methods for Determining Bacterial Activity of Antimicrobial Agents; Approved Guideline, M26AE

$90.00 $180.00

CLSI C61-A

Determination of Serum Iron, Total Iron-Binding Capacity and Percent Transferrin Saturation; Approved Standard,C61AE

$125.00 $251.96

CLSI GP11A

Basic Cost Accounting for Clinical Services; Approved Guideline, GP11-A

$145.00 $291.00